News
CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...
Evernorth said that through direct negotiations with Novo Nordisk and Eli Lilly, patients’ monthly copay costs for Wegovy (semaglutide) and Zepbound (tirzepatide) will not exceed $200. Wegovy has a ...
The problem was resolved Thursday, when lawmakers sent a $240 million supplemental budget to Governor Maura Healey, which she ...
Allison Stange lost 40 pounds since starting Zepbound in April 2024, improving both her blood pressure and sleep apnea. Now ...
Cigna’s pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.
The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.
Explore more
Illinois officials indicated that the settlement is about a larger issue than just a contract dispute with one PBM.
Bucks County, Pa. has initiated legal proceedings against major insulin manufacturers and pharmacy benefit managers (PBMs), ...
Illinois secured a $45 million settlement with CVS Caremark over pharmacy benefit management transparency issues.
SPRINGFIELD - The Illinois Office of the Attorney General (OAG) reached a settlement on behalf of the Illinois Department of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results